Yahoo! Finance
10-08-2006, 12:56 AM
Yahoo Finance Investing Picks
Motley Fool
Arrow International Keeps on Target
Friday October 6, 4:03 pm ET
By Matthew Crews
Over the past couple of years, Arrow International (Nasdaq: ARRO - News), the maker of disposable catheters and heart assist devices, has been a story of capacity constraints and falling operating margins. Two years ago, Arrow implemented a turnaround program to get the company back on the right track. With Arrow's fourth quarter and fiscal 2006 earnings now in the bag, this is a good time to perform a health checkup.
Sales were up 6% from $454.3 million in fiscal 2005 to $481.6 million in fiscal 2006. Management forecasts fiscal 2007 sales to be up another 7% to 9%. There was strength in both its critical-care and cardiac-care business. Growth was particularly noticeable in the European markets where sales were up over 12% for the year. The capacity constraints on sales growth seem to be subsiding now that both the new facilities in the Czech Republic and Mexico are up and running.
complete article here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/fool/061006/116016501223.html?.v=1)
____________________________
<a href="http://www.skousenhedgefundtrader.com/visitor.php?offer=hfs49a.html">click here to read a free report<br>
<a href="http://www.skousenhedgefundtrader.com/visitor.php?offer=hfs49a.html" target="_blank"><img src="http://www.stock-monkey.com/ads/skousen/skousen450x217.gif" alt="" border="0"></a><br>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">
Motley Fool
Arrow International Keeps on Target
Friday October 6, 4:03 pm ET
By Matthew Crews
Over the past couple of years, Arrow International (Nasdaq: ARRO - News), the maker of disposable catheters and heart assist devices, has been a story of capacity constraints and falling operating margins. Two years ago, Arrow implemented a turnaround program to get the company back on the right track. With Arrow's fourth quarter and fiscal 2006 earnings now in the bag, this is a good time to perform a health checkup.
Sales were up 6% from $454.3 million in fiscal 2005 to $481.6 million in fiscal 2006. Management forecasts fiscal 2007 sales to be up another 7% to 9%. There was strength in both its critical-care and cardiac-care business. Growth was particularly noticeable in the European markets where sales were up over 12% for the year. The capacity constraints on sales growth seem to be subsiding now that both the new facilities in the Czech Republic and Mexico are up and running.
complete article here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/fool/061006/116016501223.html?.v=1)
____________________________
<a href="http://www.skousenhedgefundtrader.com/visitor.php?offer=hfs49a.html">click here to read a free report<br>
<a href="http://www.skousenhedgefundtrader.com/visitor.php?offer=hfs49a.html" target="_blank"><img src="http://www.stock-monkey.com/ads/skousen/skousen450x217.gif" alt="" border="0"></a><br>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">